PCV99 PHARMACOECONOMICS OF DIRECT RENIN INGIBITOR ALISKIREN IN HYPERTENSION TREATMENT OF PATIENTS WITH TYPE-2 DIABETES AND NEPHROPATHY
Abstract
Authors
AV Rudakova
AV Rudakova
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now